New at CADTH — December 2021

News and Events

CADTH Therapeutic Review of Multiple Myeloma Unique in Many Aspects
The CADTH Therapeutic Review of treatments for transplant-ineligible multiple myeloma patients represents several firsts for the organization. It is our first therapeutic review in oncology, and our first involving international collaboration. Learn more about the project.

2021 CADTH Symposium: On Demand Content
If you registered for the CADTH Symposium, don’t forget that you have access to all the content, on demand, for the next 2 months.

Canadian Trends and Projections in Prescription Drug Purchases: 2001 to 2023
A new analysis by a national group of experts examined drug purchases between 2001 and 2020 in the retail and hospital sectors using the IQVIA Canadian Drugstore and Hospital Purchases Audit. It was published in Volume 1, Number 11 of the Canadian Journal of Health Technologies.

Submit an Abstract for the Choosing Wisely Canada National Meeting
Choosing Wisely Canada is now accepting abstract submissions to be featured virtually at its annual National Meeting on May 25 and May 26, 2022. Bringing together health professionals, patients, system leaders, and researchers, the National Meeting is a unique opportunity to learn about leading Choosing Wisely efforts taking place across the country. Abstracts should be based on themes related to quality improvement, measurement and evaluation, medical education, and patient engagement.

CADTH Reimbursement Reviews

We recently issued the following Reimbursement Recommendations:

• idecabtagene vicleucel (Abecma) for Multiple myeloma
• tucatinib (Tukysa) for Advanced or metastatic breast cancer
• pembrolizumab (Keytruda) for Classical Hodgkin lymphoma
• trientine hydrochloride (MAR-Trientine) for Wilson's disease
• romosozumab (Evenity) for osteoporosis in postmenopausal women
• Provisional Funding algorithm for Colorectal Cancer

CADTH Health Technology Reviews

We have published the following Health Technology Reviews:

• Homelike Models of Long-Term Care: A 2021 Update – Rapid Review
• Cardiac Monitoring for Adolescents With Eating Disorders – Rapid Review
• Nabilone for the Treatment of Post-Traumatic Stress Disorder: A 2021 Update – Rapid Review
• Lenalidomide Plus Rituximab Chemotherapy for Relapsed or Refractory Indolent B-Cell Non-Hodgkin Lymphomas – Rapid Review
• Cognitive Remediation Therapy for People With Schizophrenia Spectrum Disorder: A Rapid Qualitative Review – Rapid Review
• Computed Tomography Derived Fractional Flow Reserve for the Diagnosis of Coronary Artery Disease – Rapid Review
• Medication Administration with Inhalers or Nebulizers – Rapid Review
• Pharmacological Thromboprophylaxis in Patients With Cancer – Rapid Review
• Biologics in Plaque Psoriasis – Environmental Scan
• Remote Monitoring Programs for Cardiac Conditions – Optimal Use

CADTH Reference Lists

We have published the following Reference Lists:

• Switching From Reference to Biosimilar Insulin Aspart for Patients With Diabetes Mellitus (Type 1 or Type 2)
• Non-Medical Withdrawal Management Services for Substance Use Disorder
• Facial Gender-Affirming Procedures for Gender Dysphoria
• Vital Sign Monitoring in Long-Term Care: A 2021 Update
• Pharmacologic Interventions for the Treatment of Clozapine-Induced Hypersalivation
• Interferon Gamma for the Long-Term Treatment of Chronic Granulomatous Disease
• Remote Substance-Monitoring Devices and Mobile Applications for Substance Use Disorders
• Point-of-Care Ultrasound for Adults in Rural and Remote Healthcare Settings
• Intravenous Immunoglobulin Therapy for Neurological and Autoimmune Conditions
• Intravenous Immunoglobulin Therapy for Primary and Secondary Immune Deficiency Diseases
• Massage Therapy for Musculoskeletal Pain

Other CADTH Tools

• Hospital News Article: Smoking cessation on hospital property: Using evidence to clear the air on best practices
• Assessing and Managing Chronic Non-Cancer Pain

TELL US WHAT YOU THINK

We love hearing how our products and services are influencing health care policies, clinical practices, and patient outcomes. If you have a success story to share, please get in touch with your CADTH Liaison Officer.

CADTH E-Alerts: Subscribe to receive the latest CADTH news, reports, feedback opportunities, and events.